Authors:
JARVINEN K
AKERMAN S
SVARFVAR B
TARVAINEN T
VIINIKKA P
PARONEN P
Citation: K. Jarvinen et al., DRUG-RELEASE FROM PH AND IONIC-STRENGTH RESPONSIVE POLY(ACRYLIC ACID)GRAFTED POLY(VINYLIDENEFLUORIDE) MEMBRANE BAGS IN-VITRO, Pharmaceutical research, 15(5), 1998, pp. 802-805
Authors:
SAVOLAINEN J
JARVINEN K
TAIPALE H
JARHO P
LOFTSSON T
JARVINEN T
Citation: J. Savolainen et al., COADMINISTRATION OF A WATER-SOLUBLE POLYMER INCREASES THE USEFULNESS OF CYCLODEXTRINS IN SOLID ORAL DOSAGE FORMS, Pharmaceutical research, 15(11), 1998, pp. 1696-1701
Authors:
SAVOLAINEN J
JARVINEN K
MATILAINEN L
JARVINEN T
Citation: J. Savolainen et al., IMPROVED DISSOLUTION AND BIOAVAILABILITY OF PHENYTOIN BY SULFOBUTYLETHER-BETA-CYCLODEXTRIN ((SBE)(7M)-BETA-CD) AND HYDROXYPROPYL-BETA-CYCLODEXTRIN (HP-BETA-CD) COMPLEXATION, International journal of pharmaceutics, 165(1), 1998, pp. 69-78
Authors:
AKERMAN S
VIINIKKA P
SVARFVAR B
PUTKONEN K
JARVINEN K
KONTTURI K
NASMAN J
URTTI A
PARONEN P
Citation: S. Akerman et al., DRUG PERMEATION THROUGH A TEMPERATURE-SENSITIVE POLY(N-ISOPROPYLACRYLAMIDE) GRAFTED POLY(VINYLIDENE FLUORIDE) MEMBRANE, International journal of pharmaceutics, 164(1-2), 1998, pp. 29-36
Authors:
PATE DW
JARVINEN K
URTTI A
MAHADEVAN V
JARVINEN T
Citation: Dw. Pate et al., EFFECT OF THE CB1 RECEPTOR ANTAGONIST, SR141716A, ON CANNABINOID-INDUCED OCULAR HYPOTENSION IN NORMOTENSIVE RABBITS, Life sciences (1973), 63(24), 1998, pp. 2181-2188
Authors:
KIVIMAKI M
MAKI E
LINDSTROM K
ALANKO A
SEITSONEN S
JARVINEN K
Citation: M. Kivimaki et al., DOES THE IMPLEMENTATION OF TOTAL QUALITY MANAGEMENT (TQM) CHANGE THE WELL-BEING AND WORK-RELATED ATTITUDES OF HEALTH-CARE PERSONNEL - STUDYOF A TQM PRIZEWINNING SURGICAL CLINIC, Journal of organisational change management, 10(6), 1997, pp. 456
Authors:
PATE DW
JARVINEN K
URTTI A
JARHO P
MAHADEVAN V
JARVINEN T
Citation: Dw. Pate et al., EFFECTS OF TOPICAL ALPHA-SUBSTITUTED ANANDAMIDES ON INTRAOCULAR-PRESSURE IN NORMOTENSIVE RABBITS, Pharmaceutical research, 14(12), 1997, pp. 1738-1743
Authors:
JARHO P
JARVINEN K
URTTI A
STELLA VJ
JARVINEN T
Citation: P. Jarho et al., THE USE OF CYCLODEXTRINS IN OPHTHALMIC FORMULATIONS OF DIPIVEFRIN, International journal of pharmaceutics, 153(2), 1997, pp. 225-233
Authors:
TAPIAINEN T
JARVINEN K
PAAKKO P
BJELOGRLIC N
VAHAKANGAS K
Citation: T. Tapiainen et al., TPA DECREASES THE P53 RESPONSE TO BENZO[A]PYRENE-DNA ADDUCTS IN-VIVO IN MOUSE SKIN, Carcinogenesis, 17(6), 1996, pp. 1377-1380
Authors:
JARHO P
URTTI A
JARVINEN K
PATE DW
JARVINEN T
Citation: P. Jarho et al., HYDROXYPROPYL-BETA-CYCLODEXTRIN INCREASES AQUEOUS SOLUBILITY AND STABILITY OF ANANDAMIDE, Life sciences, 58(10), 1996, pp. 181-185
Authors:
JARHO P
JARVINEN K
URTTI A
STELLA VJ
JARVINEN T
Citation: P. Jarho et al., MODIFIED BETA-CYCLODEXTRIN (SBE7-BETA-CYD) WITH VISCOUS VEHICLE IMPROVES THE OCULAR DELIVERY AND TOLERABILITY OF PILOCARPINE PRODRUG IN RABBITS, Journal of Pharmacy and Pharmacology, 48(3), 1996, pp. 263-269
Authors:
JARVINEN T
JARVINEN K
URTTI A
THOMPSON D
STELLA VJ
Citation: T. Jarvinen et al., SULFOBUTYL ETHER BETA-CYCLODEXTRIN (SBE-BETA-CD) IN EYEDROPS IMPROVESTHE TOLERABILITY OF A TOPICALLY APPLIED PILOCARPINE PRODRUG IN RABBITS, Journal of ocular pharmacology and therapeutics, 11(2), 1995, pp. 95-106
Authors:
PATE DW
JARVINEN K
URTTI A
JARHO P
JARVINEN T
Citation: Dw. Pate et al., OPHTHALMIC ARACHIDONYLETHANOLAMIDE DECREASES INTRAOCULAR-PRESSURE IN NORMOTENSIVE RABBITS, Current eye research, 14(9), 1995, pp. 791-797
Authors:
URTTI A
PATE D
JARVINEN K
JARHO P
JARVINEN T
Citation: A. Urtti et al., OPHTHALMIC ARCHIDONYLETHANOLAMIDE DECREASES INTRAOCULAR-PRESSURE IN RABBITS, Investigative ophthalmology & visual science, 36(4), 1995, pp. 720-720
Authors:
RAMET M
CASTREN K
JARVINEN K
PEKKALA K
TURPEENNIEMIHUJANEN T
SOINI Y
PAAKKO P
VAHAKANGAS K
Citation: M. Ramet et al., P53 PROTEIN EXPRESSION IS CORRELATED WITH BENZO[ALPHA]PYRENE-DNA ADDUCTS IN CARCINOMA CELL-LINES, Carcinogenesis, 16(9), 1995, pp. 2117-2124
Authors:
JARVINEN T
JARVINEN K
SCHWARTING N
STELLA VJ
Citation: T. Jarvinen et al., BETA-CYCLODEXTRIN DERIVATIVES, SBE4-BETA-CD AND HP-BETA-CD, INCREASE THE ORAL BIOAVAILABILITY OF CINNARIZINE IN BEAGLE DOGS, Journal of pharmaceutical sciences, 84(3), 1995, pp. 295-299
Authors:
JARVINEN K
JARVINEN T
THOMPSON DO
STELLA VJ
Citation: K. Jarvinen et al., THE EFFECT OF A MODIFIED BETA-CYCLODEXTRIN, SBE4-BETA-CD, ON THE AQUEOUS STABILITY AND OCULAR ABSORPTION OF PILOCARPINE, Current eye research, 13(12), 1994, pp. 897-905